Back
15
Day Range
$98.92
$102.27
52-Week Range
$47.48
$107.90
Volume
95,784
50D / 200D Avg
$100.42
/
$81.20
Prev Close
$99.50
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 56.4 | 0.4 |
| P/B | 13.4 | 2.9 |
| ROE % | 24.8 | 3.8 |
| Net Margin % | 26.8 | 3.9 |
| Rev Growth 5Y % | 19.0 | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$120.00
+21.0%
Forward P/E
47.7
Forward EPS
$2.08
EPS Growth (est.)
+0.0%
Est. Revenue
92 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$2.32
$2.30 – $2.34
|
100 M | 1 |
| FY2026 |
$2.08
$2.07 – $2.09
|
92 M | 1 |
Key Takeaways
Revenue grew 18.99% annually over 5 years — strong growth
Earnings grew 16.88% over the past year
ROE of 24.78% indicates high profitability
Net margin of 26.82% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 17.18M in free cash flow
Growth
Revenue Growth (5Y)
18.99%
Revenue (1Y)14.43%
Earnings (1Y)16.88%
FCF Growth (3Y)77.43%
Quality
Return on Equity
24.78%
ROIC20.73%
Net Margin26.82%
Op. Margin31.20%
Safety
Debt / Equity
0.00
Current Ratio7.98
Interest Coverage0.00
Valuation
P/E Ratio
56.41
P/B Ratio13.40
EV/EBITDA46.54
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14.43% | Revenue Growth (3Y) | 13.07% |
| Earnings Growth (1Y) | 16.88% | Earnings Growth (3Y) | 14.35% |
| Revenue Growth (5Y) | 18.99% | Earnings Growth (5Y) | 24.60% |
| Profitability | |||
| Revenue (TTM) | 83.81M | Net Income (TTM) | 22.48M |
| ROE | 24.78% | ROA | 20.67% |
| Gross Margin | 76.75% | Operating Margin | 31.20% |
| Net Margin | 26.82% | Free Cash Flow (TTM) | 17.18M |
| ROIC | 20.73% | FCF Growth (3Y) | 77.43% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 7.98 |
| Interest Coverage | 0.00 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 56.41 | P/B Ratio | 13.40 |
| P/S Ratio | 15.13 | PEG Ratio | 3.35 |
| EV/EBITDA | 46.54 | Dividend Yield | 0.01% |
| Market Cap | 1.27B | Enterprise Value | 1.22B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 83.81M | 73.24M | 65.56M | 53.30M | 41.81M |
| Net Income | 22.48M | 19.23M | 17.19M | 12.83M | 9.33M |
| EPS (Diluted) | 1.75 | 1.50 | 1.35 | 1.02 | 0.74 |
| Gross Profit | 64.32M | 56.35M | 50.16M | 41.28M | 32.05M |
| Operating Income | 26.15M | 21.96M | 20.04M | 15.63M | 9.82M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 108.78M | 98.33M | 92.16M | 85.51M | 82.88M |
| Total Liabilities | 14.16M | 11.51M | 20.74M | 11.84M | 10.71M |
| Shareholders' Equity | 94.62M | 86.82M | 71.42M | 73.67M | 72.17M |
| Total Debt | 0.0 | 154,688.0 | 2.04M | 2.21M | 2.48M |
| Cash & Equivalents | 51.16M | 52.23M | 49.76M | 57.96M | 62.00M |
| Current Assets | 81.20M | 75.24M | 76.00M | 77.49M | 76.24M |
| Current Liabilities | 10.18M | 8.51M | 16.33M | 8.55M | 6.82M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#150 of 154
Recent Activity
Entered
Growth Investing (Philip Fisher)
Mar 24, 2026